Eplerenone, a New Selective Aldosterone Blocker

E-ISSN： 1873-4286|9|13|1065-1075

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.13, 2003-05, pp. : 1065-1075

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective aldosterone blockade with eplerenone in patients with congestive heart failure

By Salam Amar Mohammad

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1423-1427

Informa Healthcare

Access to resources Recommend Favorite

The aldosterone receptor – new insights?

By Fuller Peter

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 201-203

Informa Healthcare

Access to resources Recommend Favorite

Should the aldosterone-receptor antagonist – eplerenone – be used after acute myocardial infarction with left ventricular dysfunction?

By Doggrell Sheila

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1605-1607

Informa Healthcare

Access to resources Recommend Favorite

Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker?

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3753-3765

Bentham Science Publishers

Access to resources Recommend Favorite

Eplerenone in hypertension

By Burgess Ellen

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2573-2581

Informa Healthcare

Access to resources Recommend Favorite